The decision in the Hlumbane case by the Appeal Board of the FSB provides very interesting information about the Board’s powers in terms of decisions made by the Registrar of Financial Services Providers, particularly its discretionary powers. The appeal stems from a decision by the Registrar ... Read More »
The medical scheme industry has many challenges. In order for schemes to survive in the current medical climate, all members have to be constructively involved and understand both the products they have bought and how their scheme works.
Cape Medical Plan (CMP) is a mutual society and the ... Read More »
There is some controversy about alternative reimbursement models in the commercial healthcare industry. Global fees contracts - where a single payment is made to a healthcare team to cover all costs including hospitals, either monthly, or for a defined episode of care such as hip surgery – have ... Read More »
Matthew Donen, Senior Private Equity Analyst, RisCura
Mobile technology is rapidly transforming the way business is being conducted in Africa, particularly in the healthcare industry, as a result of greater internet connectivity.
With patients in Africa having to wait in long ... Read More »
By Norton Rose Fulbright
Chapter 3: Using intellectual property rights to protect distributed ledger technology
A significant amount of attention is being paid to the disruptive potential of distributed ledger technology (DLT) and many businesses are making huge investments in DLT-enabled ... Read More »
These funds seek long-term growth by investing in companies with a large market capitalisation. The market capitalisation is the total value of all shares issued by a company. These companies fall within the top 40 shares on the JSE (in terms of market capitalisation). The benchmark is the JSE Top 40 Index.